Details for 2019169041
Up to date per 03.04.2026
Actions
Details for 2019169041
Granted/Registered
European Patent
27.11.2019 A
21.09.2022 B1
24.01.2014
US
201461931506 P
11.09.2014
US
201462049326 P
22.01.2015
US
201562106301 P
C07D 487/04 20060101AFI20190802BHEP
Owner
Turning Point Therapeutics, Inc.Route 206 and Province Line Road Princeton NJ 08543US
Representative
Representative
Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT
Inventor
CUI, Jingrong JeanTurning Point Therapeutics, Inc. 10628 Science Center Drive, Suite 200 San Diego, CA 92121US
LI, YishanTurning Point Therapeutics, Inc. 10628 Science Center Drive, Suite 200 San Diego, CA 92121US
ROGERS, Evan W.Turning Point Therapeutics, Inc. 10628 Science Center Drive, Suite 200 San Diego, CA 92121US
ZHAI, DayongTurning Point Therapeutics, Inc. 10628 Science Center Drive, Suite 200 San Diego, CA 92121US
Information about Fees